Oup Management Co., LLC E Ffector Therapeutics, Inc. Transaction History
Oup Management Co., LLC
- $44.5 Million
- Q3 2023
A detailed history of Oup Management Co., LLC transactions in E Ffector Therapeutics, Inc. stock. As of the latest transaction made, Oup Management Co., LLC holds 1,025,697 shares of EFTR stock, worth $51,284. This represents 1.38% of its overall portfolio holdings.
Number of Shares
1,025,697
Previous 1,025,697
-0.0%
Holding current value
$51,284
Previous $851,000
27.73%
% of portfolio
1.38%
Previous 1.45%
Shares
1 transactions
Others Institutions Holding EFTR
# of Institutions
6Shares Held
6.53MCall Options Held
0Put Options Held
0-
Abingworth LLP London, X04.82MShares$241,1050.69% of portfolio
-
Evolution Capital Management LLC Crystal Bay, NV528KShares$26,3941.04% of portfolio
-
Parallel Advisors, LLC67.7KShares$3,3860.03% of portfolio
-
Blackstone Inc New York, NY52.3KShares$2,6170.0% of portfolio
-
Resolute Financial, LLC31KShares$1,5500.01% of portfolio
About eFFECTOR Therapeutics, Inc.
- Ticker EFTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,452,800
- Market Cap $2.07M
- Description
- eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...